Viewing Study NCT03761056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-01 @ 4:46 AM
Study NCT ID: NCT03761056
Status: COMPLETED
Last Update Posted: 2024-12-04
First Post: 2018-11-29
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma
Sponsor: Kite, A Gilead Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Lymphoma View
Keywords: